Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115445092 | 11544509 | 2 | F | 20160914 | 20150924 | 20160929 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-13SUNOX13P | SUN | TRUMAN N, NETHERCOTT D. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AFTER TREATMENT WITH OXALIPLATIN AND 5-FLUOROURACIL. CLIN COLORECTAL CANCER. 2013;MAR;12(1):70-2 | 73.00 | YR | F | Y | 0.00000 | 20160929 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115445092 | 11544509 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | UNK | U | UNKNOWN | 78818 | ||||||||
115445092 | 11544509 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115445092 | 11544509 | 1 | Colon cancer metastatic |
115445092 | 11544509 | 2 | Colon cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115445092 | 11544509 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115445092 | 11544509 | Hypertension | |
115445092 | 11544509 | Posterior reversible encephalopathy syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |